Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategies.
Klingemann
H G
HG
Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver, Canada.
Shepherd
J D
JD
Reece
D E
DE
Barnett
M J
MJ
Nantel
S H
SH
Sutherland
H J
HJ
Spinelli
J J
JJ
Phillips
G L
GL
D000208:Acute Disease; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D016026:Bone Marrow Transplantation / Q000009:adverse effects* / Q000379:methods / Q000401:mortality; D002066:Busulfan / Q000008:administration & dosage / Q000009:adverse effects; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects; D002330:Carmustine / Q000009:adverse effects; D017321:Clinical Trials, Phase I as Topic; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D003556:Cystitis / Q000139:chemically induced; D005260:Female; D006504:Hepatic Veno-Occlusive Disease / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D015994:Incidence; D007951:Leukemia, Myeloid / Q000628:therapy; D008099:Liver / Q000187:drug effects / Q000528:radiation effects; D017563:Lung Diseases, Interstitial / Q000139:chemically induced / Q000453:epidemiology; D008223:Lymphoma / Q000628:therapy; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D012189:Retrospective Studies; D012307:Risk Factors; D014916:Whole-Body Irradiation / Q000009:adverse effects*
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D016190:Carboplatin; D002066:Busulfan; D002330:Carmustine; D008727:Methotrexate